Association of Genetic Variants with Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry
Jamie L. Todd(Duke University), on behalf of the IPF-PRO Registry investigators, Andrew S. Allen(Duke University), Z. Ren(Columbia University), Megan L. Neely(Duke University), Christian Heßlinger(Boehringer Ingelheim (Germany)), Aparna Swaminathan(Duke University), Daniel F. Dilling, Thomas B. Leonard(Boehringer Ingelheim (United States)), Laurie D. Snyder(Duke University), Scott M. Palmer(Duke University), Gundula Povysil(Bridgepoint (United States)), D. Zhang(Columbia University Irving Medical Center), M.E. Strek(University of Chicago), Imre Noth(University of Virginia), H.J. Kim(University of Minnesota), David B. Goldstein(Electronic BioSciences (United States))
Cited by 0
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
|Pediatric Neurology|2021|727